CD47 and neoplasm: The importance of CD47 for LSC‐driven tumor formation was demonstrated in a series of xenograft transplantation experiments in which precoating of human AML tumor cells with an anti‐CD47 antibody prevented leukemic engraftment in immunodeficient mice.14